LAMP mit vorbörslichen NEWS + Kurs zieht an! - 500 Beiträge pro Seite
eröffnet am 28.01.04 15:29:08 von
neuester Beitrag 28.01.04 16:37:44 von
neuester Beitrag 28.01.04 16:37:44 von
Beiträge: 8
ID: 814.651
ID: 814.651
Aufrufe heute: 0
Gesamt: 334
Gesamt: 334
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 1 Stunde | 1238 | |
vor 32 Minuten | 929 | |
heute 06:33 | 635 | |
vor 1 Stunde | 606 | |
gestern 22:29 | 602 | |
vor 1 Stunde | 598 | |
vor 1 Stunde | 582 | |
vor 1 Stunde | 554 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.500,48 | -0,12 | 114 | |||
2. | 2. | 0,1795 | -84,04 | 76 | |||
3. | 4. | 2.231,78 | +1,79 | 55 | |||
4. | 17. | 2,6200 | -14,94 | 47 | |||
5. | 9. | 0,2105 | -3,22 | 42 | |||
6. | 3. | 20,740 | -6,15 | 38 | |||
7. | 7. | 0,9470 | +13,55 | 33 | |||
8. | 12. | 24,440 | +0,58 | 30 |
In den USA schonm 0,225 - 0,23!
Hier die News:
LAM Pharmaceutical Announces Opening of Beijing Office
Jump to first matched term
LEWISTON, N.Y., Jan 28, 2004 /PRNewswire-FirstCall via COMTEX/ -- LAM Pharmaceutical, Corp. (OTC Bulletin Board: LAMP; Frankfurt: LAM; Berlin: LAM), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that it has established an office in Beijing, China.
Establishing a permanent local presence in Beijing is an important step in the process of introducing LAM IPM Wound Gel(TM) to the Chinese market. Local representation will provide LAM with enhanced market knowledge and communication with potential distribution partners in this important market.
Joseph Slechta, President and Chief Executive Officer of LAM, commented, "China`s large population that includes a high percentage of the world`s diabetics makes this market a natural fit for our IPM Wound Gel(TM). The vast market size and the potential demand for our product have been confirmed by our market studies. We look forward to introducing our IPM Wound Gel(TM) into China."
About LAM Pharmaceutical, Corp.
L.A.M. Pharmaceutical, Corp., www.lampharm.com, is a biomedical company with laboratories in Lewiston, New York, and a business office in Toronto. LAM focuses on the development and commercialization of novel wound healing and transdermal drug delivery systems that offer patients, among other benefits, safer and more effective treatment for a variety of serious diseases. The technology is based on an original L.A.M. Ionic Polymer Matrix(TM) technology (L.A.M. IPM(TM)), a proprietary and patented combination (a total of 14 U.S. issued and approved patents) of electrically charged and non-charged molecules with wound-healing properties. L.A.M. IPM(TM) technology is also appropriate for use with well-established drugs, allowing for the sustained delivery of greater amounts to the target areas than is otherwise possible by oral means, thus prolonging therapeutic activity.
Statements in this press release regarding our business which are not historical facts are "forward-looking statements" that involve risks and uncertainties which could cause the Company`s actual results and financial condition to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, but are not limited to uncertainties relating to the need for additional funds and corporate partners, product liability, dependence on third parties for manufacturing and marketing, the early stage of products being marketed or under development, patent risk and competition.
L.A.M. Ionic Polymer Matrix(TM), L.A.M. IPM(TM) and IPM Wound Gel(TM) are trademarks of L.A.M. Pharmaceutical, Corp.
L.A.M. IPM Wound Gel(TM) is protected by one or more of the following patents: 5,897,880; 6,120,804; 6,007,843; 6,063,405.
Hier die News:
LAM Pharmaceutical Announces Opening of Beijing Office
Jump to first matched term
LEWISTON, N.Y., Jan 28, 2004 /PRNewswire-FirstCall via COMTEX/ -- LAM Pharmaceutical, Corp. (OTC Bulletin Board: LAMP; Frankfurt: LAM; Berlin: LAM), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that it has established an office in Beijing, China.
Establishing a permanent local presence in Beijing is an important step in the process of introducing LAM IPM Wound Gel(TM) to the Chinese market. Local representation will provide LAM with enhanced market knowledge and communication with potential distribution partners in this important market.
Joseph Slechta, President and Chief Executive Officer of LAM, commented, "China`s large population that includes a high percentage of the world`s diabetics makes this market a natural fit for our IPM Wound Gel(TM). The vast market size and the potential demand for our product have been confirmed by our market studies. We look forward to introducing our IPM Wound Gel(TM) into China."
About LAM Pharmaceutical, Corp.
L.A.M. Pharmaceutical, Corp., www.lampharm.com, is a biomedical company with laboratories in Lewiston, New York, and a business office in Toronto. LAM focuses on the development and commercialization of novel wound healing and transdermal drug delivery systems that offer patients, among other benefits, safer and more effective treatment for a variety of serious diseases. The technology is based on an original L.A.M. Ionic Polymer Matrix(TM) technology (L.A.M. IPM(TM)), a proprietary and patented combination (a total of 14 U.S. issued and approved patents) of electrically charged and non-charged molecules with wound-healing properties. L.A.M. IPM(TM) technology is also appropriate for use with well-established drugs, allowing for the sustained delivery of greater amounts to the target areas than is otherwise possible by oral means, thus prolonging therapeutic activity.
Statements in this press release regarding our business which are not historical facts are "forward-looking statements" that involve risks and uncertainties which could cause the Company`s actual results and financial condition to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, but are not limited to uncertainties relating to the need for additional funds and corporate partners, product liability, dependence on third parties for manufacturing and marketing, the early stage of products being marketed or under development, patent risk and competition.
L.A.M. Ionic Polymer Matrix(TM), L.A.M. IPM(TM) and IPM Wound Gel(TM) are trademarks of L.A.M. Pharmaceutical, Corp.
L.A.M. IPM Wound Gel(TM) is protected by one or more of the following patents: 5,897,880; 6,120,804; 6,007,843; 6,063,405.
Schon 14% im Plus!
0,225 in den USA = 0,18 in Deutschland
Aber immer noch 0,175 im ask
Aber immer noch 0,175 im ask
Warum dieser Abschlag in Germany
Nur keine Panik. Rechne den Dollarkurs in Euro um und es stimmt wieder. Also von wegen Abschlag.
Gruß
jessi
Gruß
jessi
Soagr der bid ist in den USA höher als der ask in Germany
Also ich nehme für den Euro/Dol 1,26
Bid: 0,221 = 0,176
Ask: 0,225 = 0,179
In Deutschland 0,175 im ask?
Bid: 0,221 = 0,176
Ask: 0,225 = 0,179
In Deutschland 0,175 im ask?
Man könnte auch 1,265 nehmen. Aber du hast schon recht, was für ein Abschlag. Die Aktie ist um mindestens 0,004 Euro unterbewertet.
Da muss man schon ne Menge investieren, um darauf zu spekulieren.
Entweder sie steigt, weil sie gut ist oder eben nicht.
Gruß
jessi
Da muss man schon ne Menge investieren, um darauf zu spekulieren.
Entweder sie steigt, weil sie gut ist oder eben nicht.
Gruß
jessi
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
110 | ||
76 | ||
55 | ||
42 | ||
41 | ||
38 | ||
33 | ||
31 | ||
31 | ||
31 |
Wertpapier | Beiträge | |
---|---|---|
29 | ||
29 | ||
28 | ||
28 | ||
27 | ||
26 | ||
25 | ||
24 | ||
23 | ||
22 |